Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1996 2
1997 6
1998 4
1999 3
2000 2
2001 3
2002 6
2003 7
2004 11
2005 11
2006 6
2007 5
2008 5
2009 8
2010 9
2011 8
2012 4
2013 11
2014 10
2015 8
2016 5
2017 5
2018 8
2019 4
2020 10
2021 5
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 23759449

160 results

Results by year

Filters applied: . Clear all
Page 1
Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder.
Foa EB, Simpson HB, Liebowitz MR, Powers MB, Rosenfield D, Cahill SP, Campeas R, Franklin M, Hahn CG, Hembree EA, Huppert JD, Schmidt AB, Vermes D, Williams MT. Foa EB, et al. J Clin Psychiatry. 2013 May;74(5):464-9. doi: 10.4088/JCP.12m08017. J Clin Psychiatry. 2013. PMID: 23759449 Free PMC article. Clinical Trial.
Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder.
Foa EB, Simpson HB, Rosenfield D, Liebowitz MR, Cahill SP, Huppert JD, Bender J Jr, McLean CP, Maher MJ, Campeas R, Hahn CG, Imms P, Pinto A, Powers MB, Rodriguez CI, Van Meter PE, Vermes D, Williams MT. Foa EB, et al. J Clin Psychiatry. 2015 Apr;76(4):440-6. doi: 10.4088/JCP.14m09044. J Clin Psychiatry. 2015. PMID: 25375780 Free PMC article. Clinical Trial.
Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB, Foa EB, Liebowitz MR, Huppert JD, Cahill S, Maher MJ, McLean CP, Bender J Jr, Marcus SM, Williams MT, Weaver J, Vermes D, Van Meter PE, Rodriguez CI, Powers M, Pinto A, Imms P, Hahn CG, Campeas R. Simpson HB, et al. JAMA Psychiatry. 2013 Nov;70(11):1190-9. doi: 10.1001/jamapsychiatry.2013.1932. JAMA Psychiatry. 2013. PMID: 24026523 Free PMC article. Clinical Trial.
Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.
Franklin ME, Sapyta J, Freeman JB, Khanna M, Compton S, Almirall D, Moore P, Choate-Summers M, Garcia A, Edson AL, Foa EB, March JS. Franklin ME, et al. JAMA. 2011 Sep 21;306(11):1224-32. doi: 10.1001/jama.2011.1344. JAMA. 2011. PMID: 21934055 Free PMC article. Clinical Trial.
160 results